Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 50

Sort by

Sort Order Select

Journal Articles

Quality of Life in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Improves after Minimal Residual Disease-Guided Treatment with Ibrutinib Plus Venetoclax

Blood (2024) 144 (Supplement 1): 888.

https://doi.org/10.1182/blood-2024-211226

Published: 2024

Journal Articles

Patient-Reported Quality of Life Outcomes with Venetoclax-Based First-Line Combinations in CLL: An Analysis from the Phase 3 GAIA/CLL13 Trial

Blood (2024) 144 (Supplement 1): 3238.

https://doi.org/10.1182/blood-2024-198917

Published: 2024

Journal Articles

Part a Efficacy and Safety of Oral Bruton Tyrosine Kinase Inhibitor (BTKi) Rilzabrutinib in Patients with Warm Autoimmune Hemolytic Anemia (wAIHA): Multicenter, Open-Label, Phase 2b Study

Nichola Cooper, David J Kuter, Henrik Frederiksen, Bing Han, Frederick Chen, Wilma Barcellini, Joan Cid, Catherine M. Broome, Míriam Vara, Amitabha Mazumder, Alessandro Lucchesi, Xin Zhao, Antonio M Risitano, Sumit Sawhney, Quentin A. Hill, Deepthi Jayawardene, Remco Diab, Jing Zhao, Ahmed Daak

Blood (2024) 144 (Supplement 1): 3836.

https://doi.org/10.1182/blood-2024-200325

Published: 2024

Journal Articles

A Multiomics Approach for Longitudinal Treatment Response Evaluation of Chronic Lymphocytic Leukemia Patients Receiving BTK Inhibitor Monotherapy

Marcus Høy Hansen, Sólja Remisdóttir Veyhe, Oriane Cédile, Sara Kamuk Dahlmann, Karen Juul-Jensen, Henrik Frederiksen, Mads Thomassen, Karen Dybkaer, Niels Abildgaard, Charlotte Guldborg Nyvold

Blood (2024) 144 (Supplement 1): 6768.

https://doi.org/10.1182/blood-2024-198086

Published: 2024

Journal Articles

Differences in Overall Survival for Non-Western Immigrant Patients Compared to Danish-Born Patients with Diffuse Large B-Cell Lymphoma

Mikkel Runason Simonsen, Lasse Hjort Jakobsen, Marianne Tang Severinsen, Henrik Frederiksen, Carsten Utoft Niemann, Judit Mészáros Joergensen, Michael Roost Clausen, Jørn Starklint, Søren Paaske Johnsen, Tarec Christoffer El-galaly, Joachim Baech

Blood (2023) 142 (Supplement 1): 6257.

https://doi.org/10.1182/blood-2023-179786

Published: 2023

Journal Articles

The Risk of Infections in Adults with Primary Immune Thrombocytopenia (ITP)

Anna Frandsen, Nikolaj Mannering, Dennis Lund Hansen, Tarec Christoffer Christoffer El-Galaly, Lasse Hjort Jakobsen, Henrik Frederiksen

Blood (2023) 142 (Supplement 1): 394.

https://doi.org/10.1182/blood-2023-173251

Published: 2023

Journal Articles

First-Line Venetoclax Combinations in Fit Patients with CLL: 4-Year Follow-up and NGS-Based MRD Analysis from the Phase 3 GAIA/CLL13 Trial

Blood (2023) 142 (Supplement 1): 635.

https://doi.org/10.1182/blood-2023-173709

Published: 2023

Journal Articles

Use of Psychotropic Prescription Drugs and Mental Health in Adult Patients with Primary Immune Thrombocytopenia - a Danish Nationwide Cohort Study

Nikolaj Mannering, Dennis Lund Hansen, Anton Pottegård, Henrik Frederiksen

Blood (2022) 140 (Supplement 1): 8412–8413.

https://doi.org/10.1182/blood-2022-155834

Published: 2022

Journal Articles

Thrombopoietin receptor agonists in adult Evans syndrome: an international multicenter experience

Bruno Fattizzo, Nicola Cecchi, Marta Bortolotti, Giulio Giordano, Andrea Patriarca, Andreas Glenthøj, Silvia Cantoni, Marco Capecchi, Frederick Chen, Maria Eva Mingot-Castellano, Mariasanta Napolitano, Henrik Frederiksen, Tomàs José Gonzaléz-Lopez, Wilma Barcellini

Blood (2022) 140 (7): 789–792.

https://doi.org/10.1182/blood.2022016818

Published: 2022

Journal Articles

Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease/cold agglutinin syndrome

Marit Jalink, Sigbjørn Berentsen, Jorge J. Castillo, Steven P. Treon, Marjan Cruijsen, Bruno Fattizzo, Ramona Cassin, Despina Fotiou, Efstathios Kastritis, Masja De Haas, Liesbeth E. M. Oosten, Henrik Frederiksen, Andrea Patriarca, Shirley D'Sa, Josephine M.I. Vos

Blood (2021) 138 (20): 2002–2005.

https://doi.org/10.1182/blood.2021012039

Published: 2021

Includes: Supplemental data

Journal Articles

Risk of Incident Diabetes and Dysregulated Pre-Existing Diabetes Mellitus in Newly Diagnosed Lymphoma Patients Treated with Steroid-Containing Immunochemotherapy: A Danish Population-Based Study

Joachim Baech, Marianne Tang Severinsen, Andreas Kiesbye Øvlisen, Henrik Frederiksen, Peter Vestergaard, Christian Torp-Pedersen, Judit M. Jørgensen, Michael Roost Clausen, Christian Bjørn Poulsen, Peter de Nully Brown, Anne Ortved Gang, Robert Schou Pedersen, Karin Ekstroem Smedby, Sandra Eloranta, Lasse H. Jakobsen, Tarec Christoffer El-Galaly

Blood (2021) 138 (Supplement 1): 454.

https://doi.org/10.1182/blood-2021-144733

Published: 2021

Journal Articles

Daratumumab As a Treatment for Adult Immune Thrombocytopenia: A Phase II Study with Safety Run-in (the DART Study)

Galina Tsykunova, Pal André Holme, Hoa Thi Tuyet Tran, Tor Henrik Anderson Tvedt, Ludvig Andre Munthe, Marc Michel, Henrik Frederiksen, James B Bussel, David J. Kuter, Waleed Ghanima

Blood (2021) 138 (Supplement 1): 2088.

https://doi.org/10.1182/blood-2021-151410

Published: 2021

Journal Articles

Mental Health Among Patients with Non-Hodgkin Lymphoma: A Danish Nationwide Study of Psychotropic Drug Use in 7,201 Patients and 36,005 Matched Comparators

Andreas Kiesbye Øvlisen, Lasse H. Jakobsen, Kristian Hay Kragholm, René Ernst Nielsen, Peter De Nully Brown, Rasmus Bo Dahl-Soerensen, Henrik Frederiksen, Nikolaj Mannering, Pär L. Josefsson, Ahmed Al-Mashhadi, Judit M. Jørgensen, Andriette Dessau-Arp, Michael Roost Clausen, Robert Schou Pedersen, Christian Torp-Pedersen, Marianne Tang Severinsen, Tarec Christoffer El-Galaly

Blood (2021) 138 (Supplement 1): 51.

https://doi.org/10.1182/blood-2021-150163

Published: 2021

Journal Articles

Increased Risk of Ischemic Stroke Amongst Patients with Primary Autoimmune Hemolytic Anemia in Denmark and France

Dennis Lund Hansen, Julien Maquet, Margaux Lafaurie, Sigbjørn Berentsen, Henrik Frederiksen, Guillaume Moulis, David Gaist

Blood (2021) 138 (Supplement 1): 849.

https://doi.org/10.1182/blood-2021-151615

Published: 2021

Journal Articles

Efficacy of Thrombopoietin Receptor Agonists in Evans Syndrome: An International Multicenter Experience

Nicola Cecchi, Juri Alessandro Giannotta, Andrea Patriarca, Andreas Glenthøj, Maria Eva Mingot, Frederick Chen, Silvia Cantoni, Dennis Lund Hansen, Marco Capecchi, Henrik Frederiksen, Tomas Jose Gonzalez-Lopez, Wilma Barcellini, Bruno Fattizzo

Blood (2021) 138 (Supplement 1): 3155.

https://doi.org/10.1182/blood-2021-149383

Published: 2021

Journal Articles

Time-Limited Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (R/R CLL) Who Have Undetectable MRD - Primary Analysis from the Randomized Phase II Vision HO141 Trial

Blood (2021) 138 (Supplement 1): 69.

https://doi.org/10.1182/blood-2021-148630

Published: 2021

Journal Articles

A Randomized Phase III Study of Venetoclax-Based Time-Limited Combination Treatments (RVe, GVe, GIVe) Vs Standard Chemoimmunotherapy (CIT: FCR/BR) in Frontline Chronic Lymphocytic Leukemia (CLL) of Fit Patients: First Co-Primary Endpoint Analysis of the International Intergroup GAIA (CLL13) Trial

Blood (2021) 138 (Supplement 1): 71.

https://doi.org/10.1182/blood-2021-146161

Published: 2021

Journal Articles

Labor Market Attachment in Patients with Myeloproliferative Neoplasms: A Nationwide Matched Cohort Study

Sarah Friis Christensen, Lise Skovgaard Svingel, Anders Kjærsgaard, Anna Stenling, Björn Paulsson, Christen Lykkegaard Andersen, Christian Fynbo Christiansen, Jesper Stentoft, Jørn Starklint, Marianne Tang Severinsen, Mette Borg Clausen, Morten Hagemann Hilsøe, Henrik Frederiksen, Hans C. Hasselbalch, Marie Bak, Ellen Margrethe Mikkelsen

Blood (2021) 138 (Supplement 1): 3627.

https://doi.org/10.1182/blood-2021-144587

Published: 2021

Journal Articles

The Impact of the COVID-19 Pandemic on Quality of Life in Danish Patients with Multiple Myeloma; Results from an Ongoing Longitudinal National Survey

Louise Redder, Sören Möller, Anna Thit Johnsen, Mary Jarden, Christen lykkegaard Andersen, Henrik Frederiksen, Henrik Gregersen, Anja Klostergaard, Morten Saaby Steffensen, Per Troellund Pedersen, Maja Hinge, Mikael Frederiksen, Carsten Helleberg, Niels Abildgaard, Lene Kongsgaard Nielsen

Blood (2021) 138 (Supplement 1): 1638.

https://doi.org/10.1182/blood-2021-147707

Published: 2021

Journal Articles

Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia

Blood (2021) 137 (8): 1117–1120.

https://doi.org/10.1182/blood.2020008608

Published: 2021

Includes: Supplemental data

NARROW

Quality of Life in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Improves after Minimal Residual Disease-Guided Treatment with Ibrutinib Plus Venetoclax

Patient-Reported Quality of Life Outcomes with Venetoclax-Based First-Line Combinations in CLL: An Analysis from the Phase 3 GAIA/CLL13 Trial

Part a Efficacy and Safety of Oral Bruton Tyrosine Kinase Inhibitor (BTKi) Rilzabrutinib in Patients with Warm Autoimmune Hemolytic Anemia (wAIHA): Multicenter, Open-Label, Phase 2b Study

A Multiomics Approach for Longitudinal Treatment Response Evaluation of Chronic Lymphocytic Leukemia Patients Receiving BTK Inhibitor Monotherapy

Differences in Overall Survival for Non-Western Immigrant Patients Compared to Danish-Born Patients with Diffuse Large B-Cell Lymphoma

The Risk of Infections in Adults with Primary Immune Thrombocytopenia (ITP)

First-Line Venetoclax Combinations in Fit Patients with CLL: 4-Year Follow-up and NGS-Based MRD Analysis from the Phase 3 GAIA/CLL13 Trial

Use of Psychotropic Prescription Drugs and Mental Health in Adult Patients with Primary Immune Thrombocytopenia - a Danish Nationwide Cohort Study

Thrombopoietin receptor agonists in adult Evans syndrome: an international multicenter experience

Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease/cold agglutinin syndrome

Risk of Incident Diabetes and Dysregulated Pre-Existing Diabetes Mellitus in Newly Diagnosed Lymphoma Patients Treated with Steroid-Containing Immunochemotherapy: A Danish Population-Based Study

Daratumumab As a Treatment for Adult Immune Thrombocytopenia: A Phase II Study with Safety Run-in (the DART Study)

Mental Health Among Patients with Non-Hodgkin Lymphoma: A Danish Nationwide Study of Psychotropic Drug Use in 7,201 Patients and 36,005 Matched Comparators

Increased Risk of Ischemic Stroke Amongst Patients with Primary Autoimmune Hemolytic Anemia in Denmark and France

Efficacy of Thrombopoietin Receptor Agonists in Evans Syndrome: An International Multicenter Experience

Time-Limited Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (R/R CLL) Who Have Undetectable MRD - Primary Analysis from the Randomized Phase II Vision HO141 Trial

A Randomized Phase III Study of Venetoclax-Based Time-Limited Combination Treatments (RVe, GVe, GIVe) Vs Standard Chemoimmunotherapy (CIT: FCR/BR) in Frontline Chronic Lymphocytic Leukemia (CLL) of Fit Patients: First Co-Primary Endpoint Analysis of the International Intergroup GAIA (CLL13) Trial

Labor Market Attachment in Patients with Myeloproliferative Neoplasms: A Nationwide Matched Cohort Study

The Impact of the COVID-19 Pandemic on Quality of Life in Danish Patients with Multiple Myeloma; Results from an Ongoing Longitudinal National Survey

Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only